Shiga T, Wajima Z, Inoue T, Sakamoto A. Predicting difficult intubation in apparently normal patients: a meta-analysis of bedside screening test performance. Anesthesiology. 2005;103(2):429–37.
 Liu H, Zhou T, Wei J. Comparison between remifentanil and dexmedetomidine for sedation during modified awake fiberoptic intubation. Exp Ther Med. 2015;9(4):1259–64.
 Rosenstock CV, Thogersen B, Afshari A, Christensen AL, Eriksen C, Gatke MR. Awake fiberoptic or awake video laryngoscopic tracheal intubation in patients with anticipated difficult airway management: a randomized clinical trial. Anesthesiology. 2012;116(6):1210–6.
 Mendonca C, Mesbah A, Velayudhan A, Danha R. A randomised clinical trial comparing the flexible fibrescope and the Pentax Airway Scope (AWS)(®)for awake oral tracheal intubation. Anaesthesia. 2016;71(8):908–14.
 Tsai CJ, Chu KS, Chen TI, Lu DV, Wang HM, Lu IC. A comparison of the effectiveness of dexmedetomidine versus propofol target-controlled infusion for sedation during fibreoptic nasotracheal intubation. Anaesthesia. 2010;65(3):254–9.
 He XY, Cao J, He Q, Shi XY. Dexmedetomidine for the management of fibreoptic intubation. Cochrane Db Syst Rev [Online serial]. 2014;1(1):CD009798.
 Li CW, Li YD, Tian HT, Kong XG, Chen K. Dexmedetomidine-midazolam versus sufentanil-midazolam for awake fiberoptic nasotracheal intubation: A randomized double-blind study, Chin. Med. J. (Engl). 2015;128(023):3143–8.
 Cabrini L, Baiardo RM, Ball L. Awake Fiberoptic Intubation Protocols in the Operating Room for Anticipated Difficult Airway: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2019;128(5):971–80.
 Schmid RL, Sandler AN, Katz J. Use and efficacy of low-dose ketamine in the management of acute postoperative pain: A review of current techniques and outcomes. Pain. 1999;82(2):111–25.
 Ferguson I, Alkhouri H, Fogg T, Aneman A. Ketamine use for rapid sequence intubation in Australian and New Zealand emergency departments from 2010 to 2015: A registry study. Emerg Med Australas. 2019;31(2):205–10.
 Mogahd MM, Mahran MS, Elbaradi GF. Safety and efficacy of ketamine-dexmedetomidine versus ketamine-propofol combinations for sedation in patients after coronary artery bypass graft surgery. Ann Card Anaesth. 2017;20(2):182–7.
 Chen J-Y, Jia J-E, Liu T-J, Qin M-J, Li W-X. Comparison of the effects of dexmedetomidine, ketamine, and placebo on emergence agitation after strabismus surgery in children. Can J Anesth Can d’anesthésie. 2013;60(4):385–92.
 Chun EH, Han MJ, Baik HJ, Park HS, Chung RK, Han JI. Dexmedetomidine-ketamine versus Dexmedetomidine-midazolam-fentanyl for monitored anesthesia care during chemoport insertion: A Prospective Randomized Study. BMC Anesthesiol. 2016;16(1):1–9.
 Li A, Yuen VM, Goulay-Dufaÿ S, Sheng Y, Standing JF, Kwok PCL. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine. Br J Anaesth. 2018;120(5):960–8.
 Thronæs M, Popper L, Eeg M, Jaatun E, Kvitberg M, Kaasa S. Efficacy and Tolerability of Intranasal Fentanyl Spray in Cancer Patients with Breakthrough Pain. Clin Ther. 2015;37(3):585–96.
 Foster D, Upton R, Christrup L, Popper L. Pharmacokinetics and pharmacodynamics of intranasal versus intravenous fentanyl in patients with pain after oral surgery. Ann Pharmacother. 2008;42(10):1380–7.
 Chew KS, Shaharudin AH. An open-label randomised controlled trial on the efficacy of adding intranasal fentanyl to intravenous tramadol in patients with moderate to severe pain following acute musculoskeletal injuries. Singapore Med J. 2017;58(10):601–5.
 Yanagihara Y, Ohtani M, Kariya S, Uchino K, Hiraishi T, Ashizawa N. Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers. Biopharm Drug Dispos. 2003;24(1):37–43.
 Bement MH, Weyer A, Keller M, Harkins AL, Hunter SK. Anxiety and stress can predict pain perception following a cognitive stress. Physiology and Behavior, 2010, 101(1):87-92.
 Devlin J. Motor activity assessment scale; a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999;27(7):1271.
 Zhang Y, Shan GJ, Zhang YX, Cao SJ, Zhu SN, Li HJ. Propofol compared with sevoflurane general anaesthesia is associated with decreased delayed neurocognitive recovery in older adults. Br J Anaesth. 2018;121(3):595–604.
 Cattano D, Lam NC, Ferrario L, Seitan C, Vahdat K, Wilcox DW. Dexmedetomidine versus remifentanil for sedation during awake fiberoptic intubation. Anesthesiol Res Pract. 2015;2012(9):753107.
 Shen SL, Xie Y hong, Wang WY, Hu SF, Zhang YL. Comparison of dexmedetomidine and sufentanil for conscious sedation in patients undergoing awake fibreoptic nasotracheal intubation: A prospective, randomised and controlled clinical trial. Clin Respir J. 2014;8(1):100–7.
 Hu R, Liu JX, Jiang H. Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: A double-blinded randomized controlled trial. J Anesth. 2013;27(2):211–7.
 Soliman PT, Langley G, Munsell MF, Vaniya HA, Frumovitz M, Ramirez PT. Analgesic and antiemetic requirements after minimally invasive surgery for early cervical cancer: A comparison between laparoscopy and robotic surgery. Ann Surg Oncol. 2013;20(4):1355–9.
 El Mourad MB, Elghamry MR, Mansour RF, Afandy ME. Comparison of intravenous dexmedetomidine-propofol versus ketofol for sedation during awake fiberoptic intubation: A prospective, randomized study. Anesthesiol Pain Med. 2019;9(1):1–8.
 Xu T, Li M, Ni C, Guo XY. Dexmedetomidine versus remifentanil for sedation during awake intubation using a Shikani optical stylet: A randomized, double-blinded, controlled trial. BMC Anesthesiol. 2015;16(1):52.
 Kumar P, Kaur T, Atwal GK, Bhupal JS, Basra AK. Comparison of intubating conditions using fentanyl plus propofol versus fentanyl plus midazolam during fiberoptic laryngoscopy. J Clin Diagnostic Res. 2017;11(7):UC21-UC24.
 Palareti G, Legnani C, Cosmi B, Antonucci E, Erba N, Poli D. Comparison between different D-Dimer cutoff values to assess the individual risk of recurrent venous thromboembolism: Analysis of results obtained in the DULCIS study. Int J Lab Hematol. 2016;38(1):42–9.
 Mercadante S, Prestia G, Adile C, Casuccio A. Intranasal fentanyl versus fentanyl pectin nasal spray for the management of breakthrough cancer pain in doses proportional to basal opioid regimen. J Pain. 2014;15(6):602–7.
 Saleh AJ, Zhang L, Hadi SM, Ouyang W. A priming dose of intravenous ketamine-dexmedetomidine suppresses fentanyl-induced coughing: A double-blind, randomized, controlled study. Ups J Med Sci. 2014;119(4):333–7.
 Farnia MR, Jalali A, Vahidi E, Momeni M, Seyedhosseini J, Saeedi M. Comparison of intranasal ketamine versus IV morphine in reducing pain in patients with renal colic. Am J Emerg Med. 2017;35(3):434–7.
 Andolfatto G, Innes K, Dick W, Jenneson S, Willman E, Stenstrom R. Prehospital Analgesia With Intranasal Ketamine: A Randomized Double-Blind Trial in Adults. Ann Emerg Med. 2019;74(2):241–50.